|
|
|
|
|
|
|
|
CONCLUSIONS: In overall performance, the PAT is at least comparable to the Myriad II and Penn II models in screening women appropriate for genetic referral. Simplicity and identification of families with non-BRCA hereditary BC syndromes suggest that the PAT is better suited for BC risk screening.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.